The anthrax situation in the northeastern province of Mukdahan is improving, with no new cases reported as of yesterday, according to the Public Health Ministry.Public Health Minister Somsak Thepsutin ...

Piperacillin effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline. At such a low ...

WBZ-TV's Dr. Mallika Marshall reports that researchers at Northwestern University found the drug Piperacillin to be more ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

This smaller dose, combined with the drug’s targeted action against the infection ... Read more How to tell if your immune ...

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, ...

What if you could lose weight with a daily pill instead of painful weekly jabs like you would with Ozempic, the injectable form of semaglutide that controls both blood sugar and obesity? US ...

MACOMB COUNTY, MI - Thousands of pills, various narcotics, weapons - including assault rifles - and thousands of dollars were seized in searches by Michigan State Police this week The County of ...

The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.

The successful trial of a daily weight-loss pill has been hailed as a “landmark moment” in the fight against obesity, with Ireland’s leading expert in the field describing it as a “huge ...

FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug ...